enGene
The Senior Scientist, Analytical, at enGene will play a central role in supporting development of a novel gene therapy platform by leading analytical activities. The role focuses on overseeing analytical aspects of technology transfer, method validation, and regulatory documentation for late-phase development and commercialization. It is embedded within an analytical group that collaborates closely with internal teams and external partners. The position supports enGene’s genetic medicines programs, including its lead candidate for non-muscle invasive bladder cancer.
Headquarters
Boston, Massachusetts, United States
Company Size
11-50 employees
Founded
1999
enGene is a biotechnology company focused on mainstreaming gene therapy by developing non-viral therapeutic approaches. Its lead investigational candidate, detalimogene, is being advanced for the treatment of non‑muscle invasive bladder cancer (NMIBC). The company’s stated goal is to reduce treatment burden and improve patient outcomes through a safer, non‑viral gene therapy platform. enGene positions itself to translate gene therapy into more widely accessible standard-of-care options.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for enGene.
What Heeseung's exit means for ENHYPEN, fans
5 days ago